Category Archives: Dangerous Drugs

Drugs and Pharmaceutical industry

January 25, 2012 | by Shirley

Yaz, Yasmin, Ocella

YAZ, Yasmin, and Ocella are birth control pills manufactured by Bayer Pharmaceuticals. Ocella is the generic form of Yasmin and is manufactured by Barr Laboratories. What makes these three medications different from other birth control pills is the addition of a … Continue reading →

September 2, 2011 | by ben

Actos (pioglitazone) and Bladder Cancer – FDA Warning

Actos (pioglitazone) is one of the largest-selling oral medications sold to control blood sugar levels.   Millions of prescriptions for this medication are filled each year by diabetics.  Because of the millions of prescriptions written for this medication, when the FDA recently issued an … Continue reading →

June 9, 2011 | by Shirley

Prescription Medications and Birth Defects

  It can’t get any more heart-wrenching.  Your baby is born, the doctor turns to you and says, “we have a problem”.    Your baby has a birth defect.  Questions flood into your mind.  Eventually one your questions will be “What … Continue reading →

March 14, 2011 | by Shirley

Topamax and Topiramate Linked to Birth Defects

On March 4, 2011, the FDA issued a safety alert regarding birth defects and the medication Topamax and its generic form, topiramate.  Topamax is prescribed for epileptics as an anti-convulsant medication which can help with certain types of seizures.  The medication can … Continue reading →

December 2, 2010 | by Shirley

FDA Recalls Darvon, Darvocet, Propoxyphene Medication Due to Heart Issues

Darvon and Darvocet, are medications which have been prescribed to relieve mild to moderate pain for many years.  Proproxyphene is the active ingredient in these medications.  It is also the generic form of these medications.  There has been concern over the safety … Continue reading →

August 17, 2010 | by Shirley

Chantix and Pfizer – Stealth Advertising

Can there be an ad for a drug where the drug isn’t even mentioned?   Consumers Reports wrote a blog article titled, “Pfizer and Chantix: Stealth advertising at its finest”, on this topic.  In their blog they state,  ”If this sounds … Continue reading →

August 6, 2010 | by Shirley

Avandia – The FDA Advisory Committee Vote

So after the FDA Avandia committee’s review of 900 plus pages of documents and two days of presentations, what was the vote?    There were 33 total committee members and the results were as follows: – 12 voted to remove Avandia … Continue reading →

July 30, 2010 | by Shirley

The FDA and Avandia – The Committee Meeting

The FDA 33 member committee meeting regarding Avandia offered some interesting insights regarding the diverse opinions held in connection with this drug.  We found this CBS News report interesting.

July 9, 2010 | by Shirley

The FDA and Avandia – The FDA has decided to…?

Next week is a big one for the pharmaceutical giant GlaxoSmithKline, manufacturer of the diabetes drug, Avandia.  Avandia’s  fate is going to be decided by the FDA following two days of meetings on July 13 and 14.  Avandia, the once blockbuster diabetes … Continue reading →

May 14, 2010 | by Shirley

YAZ, Yasmin, Ocella – The Number of Lawsuits Explode

Late last year the number of lawsuits which were reportedly filed against the manufacturers of  YAZ, Yasmin and Ocella totalled approximately 150.   Here is an update.  The Bayer Pharmaceutical Annual Report 2009 which was published on February 26, 2010,  stated … Continue reading →